ELLIE KIM: Open Payments
NPI 1619695608 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 29 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $158 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 13 | $210 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Geron Corporation | 1 | $66 |
| Rigel Pharmaceuticals, Inc. | 2 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| ABBVIE INC. | 1 | $30 |
| Kite Pharma, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $27 |
| Syndax Pharmaceuticals, Inc. | 1 | $24 |
Products named: Vanflyta, CALQUENCE, RYTELO, TAVALISSE, LYNOZYFIC, INJECTAFER, DATROWAY, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
